On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Bico Group AB's own share of each project, not the project's full budget.
- Horizon 2020€4.3M · 7 projects
- Horizon Europe€0 · 4 projects
Projects
11 EU-funded projects, newest first. Bico Group AB led 1 of them as coordinator. Each links to the official record.
- iRETINAAssociated partner
Development of a multilayered and bioprinted iPSC-derived retinal model with use in preclinical and toxicological testing
Horizon Europe · 2023–2026 · Project on CORDIS ↗
- OpenMINDPartner
Opto-Electronic Neural Connectoid Model Implemented for Neurodegenerative Disease
Horizon Europe · 2022–2026 · Project on CORDIS ↗
- PRISM-LTPartner
PRInted Symbiotic Materials as a dynamic platform for Living Tissues production
Horizon Europe · 2022–2027 · Project on CORDIS ↗
- BioProSPartner
Biointelligent Production Sensor to Measure Viral Activity
Horizon Europe · 2022–2026 · Project on CORDIS ↗
- LIFESAVERPartner
Living Impact on Fetal Evolution: Shelter-Analyze-Validate-Empower Regulations
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
- TRiAnklePartner
3D BIOPRINTED PERSONALISED SCAFFOLDS FOR TISSUE REGENERATION OF ANKLE JOINT
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€479ktheir share - REPAIRPartner
RESTORING CARDIAC MECHANICAL FUNCTION BY POLYMERIC ARTIFICIAL MUSCULAR TISSUE
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
€270ktheir share - GIOTTOPartner
Active aGeIng and Osteoporosis: The next challenge for smarT nanobiOmaterials and 3D technologies
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
€300ktheir share - TUMOURPRINTCoordinator
High Throughput Bioprinting of Tumour Models for Drug Development and Oncology Research
Horizon 2020 · 2018–2021 · Project on CORDIS ↗
€2.5Mtheir share - SilkFUSIONPartner
Genetically engineered human pluripotent stem cells, functionalized silk-fibroin platforms and bio-inks: a novel solution for large-scale ex-vivo platelet production, transfusion and drug research
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
€344ktheir share - CENSUSPartner
Cell-Based Models for Neurodegeneration Study and Use in Screening
Horizon 2020 · 2016–2019 · Project on CORDIS ↗
€453ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Cellink Bioprinting ABSweden · 5 shared projects
- Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 2 shared projects
- Universiteit MaastrichtNetherlands · 2 shared projects
- ElvesysFrance · 2 shared projects
- Microfluidics Innovation CenterFrance · 2 shared projects
- The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 1 shared project
- Technische Universiteit DelftNetherlands · 1 shared project
- Danmarks Tekniske UniversitetDenmark · 1 shared project
- Consiglio Nazionale Delle RicercheItaly · 1 shared project
- Politecnico di MilanoItaly · 1 shared project
- Technische Universiteit EindhovenNetherlands · 1 shared project
- Stichting Radboud UniversiteitNetherlands · 1 shared project
- Lunds UniversitetSweden · 1 shared project
- Chalmers Tekniska Hogskola ABSweden · 1 shared project
- Idryma Technologias Kai ErevnasGreece · 1 shared project
- University of StuttgartGermany · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- additive manufacturing
- anatomy and morphology
- bacteriology
- biomaterials
- biomolecules
- cardiology
- census
- dementia
- drug discovery
- embryology
- fetal medicine
- gene therapy
- immunology
- implants
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.
